CAT No: CP25387
CAS No:15177-67-0
Synonyms/Alias:15177-67-0;TRANS-1,4-CYCLOHEXANEDICARBOXYLICACIDMONOMETHYLESTER;trans-4-(Methoxycarbonyl)cyclohexanecarboxylicacid;1011-85-4;cis-4-(Methoxycarbonyl)cyclohexanecarboxylicacid;4-(methoxycarbonyl)cyclohexanecarboxylicacid;32529-79-6;(1r,4r)-4-(methoxycarbonyl)cyclohexanecarboxylicacid;4-Carbomethoxy-cyclohexane-1-carboxylicacid;trans-4-carbomethoxycyclohexane-1-carboxylicacid;SBB059422;(1r,4r)-4-(methoxycarbonyl)cyclohexane-1-carboxylicacid;TRANS-CYCLOHEXANE-1,4-DICARBOXYLICACIDMONOMETHYLESTER;cis-4-Carbomethoxycyclohexane-1-carboxylicacid;Methyltrans-4-carboxycyclohexane-1-carboxylate;4-(methoxycarbonyl)cyclohexane-1-carboxylicacid;(1s,4s)-4-(methoxycarbonyl)cyclohexanecarboxylicacid;trans-4-(Methoxycarbonyl)cyclohexane-1-carboxylicacid;NSC167365;AC1L6QQY;KSC005Q4F;SCHEMBL107582;SCHEMBL145756;SCHEMBL595940;SCHEMBL13929449
Chemical Name:trans-Cyclohexane-1,4-dicarboxylic acid monomethyl ester
2. Emu oil in combination with other active ingredients for treating skin imperfections
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.